80 FR 62 pg. 17459 - Prospective Grant of Start-Up Exclusive Evaluation Option License Agreement: Pre-Clinical Evaluation and Commercial Development of Anti-Tyrosine Kinase-Like Orphan Receptor 1 Antibody-Drug Conjugates for the Treatment of Human Cancers
Type: NOTICEVolume: 80Number: 62Page: 17459
Page: 17459FR document: [FR Doc. C1-2015-06486 Filed 3-31-15; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Prospective Grant of Start-Up Exclusive Evaluation Option License Agreement: Pre-Clinical Evaluation and Commercial Development of Anti-Tyrosine Kinase-Like Orphan Receptor 1 Antibody-Drug Conjugates for the Treatment of Human Cancers
Correction
In notice document 2015-06486 appearing on pages 15226-15227 in the issue of Monday, March 23, 2015 make the following correction:
On page 15226, in the third column, under the DATES heading, in the last line, "April 6, 2015" should read "April 7, 2015".
[FR Doc. C1-2015-06486 Filed 3-31-15; 8:45 am]
BILLING CODE 1505-01-P